China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-01

Study Completion Date

2028-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A multi-center registration study of clinical characteristics of amyotrophic lateral sclerosis (ALS) patients with traditional Chinese medicine (TCM).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

China Stroke Registry for Patients With Traditional Chinese Medicine

NCT04921397

Ischemic Stroke Intracerebral Hemorrhage

UNKNOWN

A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients

NCT05454397

Acute Stroke

UNKNOWN

SouthErn China REgisTry for Stroke on Traditional Chinese Medicine

NCT03380481

Stroke Cerebral Infarction Transient Ischemic Attack +2 more

UNKNOWN

Chinese Medicine WT for Spinocerebellar Ataxia Type 3

NCT05038306

Ataxia, Spinocerebellar Insulin-Like Growth Factor I Medicine, Chinese Traditional

COMPLETED PHASE2

Acute Ischemic Apoplexy Syndrome Specificity and Acupuncture Intervention Research

NCT04528472

Acute Ischemia

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The CARE-TCM is a prospective, multi-center, patient registry study. Eligible ALS patients with TCM treatments will be enrolled in the registry. After enrollment, this research collects the individual characteristics of patients' status. Longitudinal follow-up data are collected from both patients (primary caregivers) and their treating neurologists every 3 months for 5 years. The aims of the CARE-TCM are to: 1) explore the general characteristics of ALS patients with TCM and; 2) assess the effectiveness and safety of various TCMs on ALS based on nationwide registry outcome collecting process.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amyotrophic Lateral Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Amyotrophic lateral sclerosis patients

Amyotrophic lateral sclerosis patients with traditional Chinese medicine

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18 years and older.
* Patients with possible, laboratory supported probable, probable, or definite ALS according to the revised El Escorial criteria.
* ALS patients treated with traditional Chinese medicine.